UBS revised its stance on Beiersdorf AG on Tuesday, moving the German consumer goods group from a sell rating to neutral while cutting its 12-month price objective by 11% to €80 from €90. The change follows sustained underperformance of Beiersdorf shares versus the wider sector - the stock has slid about 20% since the start of 2026 compared with a roughly 7% decline across the sector, and has fallen around 44% over the past 24 months while the sector remained roughly flat.
On March 30 the shares were quoted at €75.40, leaving only modest upside to UBS's reduced target. The bank also discloses a position in Beiersdorf of at least 0.5% of listed shares, either long or short.
Valuation and relative multiples
UBS's note highlights that Beiersdorf now trades at about 17x estimated 2026 price-to-earnings and roughly 7x EV/EBITDA. That valuation is described as a blended 20% discount to the EU Food & HPC sector, which the research note cites as trading at 17.5x P/E and 11.5x EV/EBITDA. UBS observes that the company's current P/E multiple sits well below its 10-year P/E average of 27x.
The research team states that the bank's discounted cash flow-derived target implies a degree of upside despite what it labels conservative near-term assumptions - specifically a Consumer organic sales growth (OSG) contraction of 0.2% in 2026 and a 70 basis point reduction in operating margin in the same year, followed by a 100 basis point margin reset in 2027 and prudent medium-term forecasts of 3-4% OSG with moderate annual margin expansion beyond 2028.
Earnings revisions and assumptions
UBS trimmed its adjusted earnings per share estimates for Beiersdorf, lowering 2026 EPS by 4% to €4.27 and cutting 2027 EPS by 11% to €4.21. These revised forecasts compare with consensus figures of €4.47 for 2026 and €4.76 for 2027. For 2027 the bank assumes the group will raise brand support by about €100 million, equivalent to roughly 1.2% of sales, in line with the group's 2019 reset.
First-quarter outlook and product-line detail
For the first quarter of 2026 UBS expects organic consumer sales to decline 4.8% and Tesa sales to fall 2.5%. Those projected falls are materially larger than Visible Alpha consensus forecasts, which UBS cites as calling for first-quarter declines of 1.9% for consumer organic sales and 0.9% for Tesa.
UBS expects La Prairie sales to decrease by about 20% in Q1. The research note attributes that decline in part to the Chapter 11 filing by Saks in January, which represented roughly 40% of La Prairie's U.S. turnover, and to a temporary suspension of the Sunrise app in China. UBS also forecasts a 6% organic sales decline for Nivea in the quarter. The group is scheduled to publish its first-quarter trading update on April 21.
Offsetting some weakness, UBS projects the Derma franchise to expand by approximately 8% in Q1.
Revenue and margin trajectory
UBS forecasts group revenues of €9.82 billion for 2026, a 0.4% decrease from €9.85 billion in 2025, with a rebound to €10.09 billion projected for 2027. The bank models a contraction in the 2026 EBIT margin of 62 basis points to 13.4%, followed by a further 82 basis point reduction to 12.5% in 2027 and a moderate recovery to 12.8% in 2028. UBS's estimates show Consumer division EBIT at €1.05 billion for 2026 and €992 million for 2027.
Market positioning and sentiment indicators
Short interest in Beiersdorf has climbed sharply, reaching 9.8% of free float as of March 23, 2026, up from 0.5% in September 2024, according to UBS Data Solutions. UBS's reverse discounted cash flow analysis suggests the market is currently pricing in 1.8% OSG for the 2026-2030 period, with the EBIT margin assumed to decline by 14 basis points annually through 2030.
The research note sets out scenario assumptions that define potential valuation bounds. An upside case with a €87 stock level assumes group OSG of 3.9% for 2027-2030 and a 2030 EBIT margin of 13.6%, producing an EPS of €5.08. Conversely, a downside scenario valued at €65 assumes 1.3% OSG and a 12.5% EBIT margin in 2030.
Investors will be watching the company's April 21 trading update for the first direct management commentary on the quarter and any confirmation of the top-line and margin developments modelled by UBS.